Sutro Biopharma, Inc. (NASDAQ: STRO) Investor Investigation over possible Violations of Securities Laws

An investigation on behalf of investors of Sutro Biopharma, Inc. (NASDAQ: STRO) shares over potential securities laws violations by Sutro Biopharma, Inc. and certain of its directors and officers in connection with certain financial statements was announced.

Investors who purchased shares of Sutro Biopharma, Inc. (NASDAQ: STRO), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Sutro Biopharma, Inc. (NASDAQ: STRO) concerning whether a series of statements by Sutro Biopharma, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

San Francisco, CA based Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company.
In September 2018, Sutro Biopharma, Inc conducted its initial public offering ("IPO"), selling 5,667,000 shares of common stock priced at $15.00 per share.

On May 11, 2020, post-market, Sutro Biopharma, Inc announced its financial and operating results for the first quarter of 2020. For the quarter, Sutro Biopharma, Inc reported a net loss per share of $0.84 on revenues of $7.15 million, both of which metrics fell significantly short of consensus estimates.

On May 14, 2020, shares of Sutro Biopharma, Inc. (NASDAQ: STRO) declined to as low as $7.81 per share.

Those who purchased shares of Sutro Biopharma, Inc. (NASDAQ: STRO) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.